tiprankstipranks
Trending News
More News >
Kimball Electronics (KE)
NASDAQ:KE

Kimball Electronics (KE) AI Stock Analysis

Compare
166 Followers

Top Page

KE

Kimball Electronics

(NASDAQ:KE)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
$24.50
▲(5.29% Upside)
Action:ReiteratedDate:02/07/26
The score is driven primarily by mixed financial performance (thin margins and slightly declining TTM revenue, but solid recent free cash flow and improved leverage). The latest earnings call is a positive offset due to raised FY2026 guidance and improving margins/cash flow, while weak technical momentum and a relatively high P/E for the company’s current profitability keep the overall score in the low 60s.
Positive Factors
Strong free cash flow and improved liquidity
Sustained positive operating cash flow (eight consecutive quarters) and sizable recent FCF provide durable internal funding for capex, CMO ramps, debt reduction and selective buybacks. Strong liquidity reduces refinancing risk and supports investments that can improve margins and long-term competitiveness.
Expanding medical CMO capacity and capabilities
Adding large onshore medical CMO capacity targets a higher-growth, higher-margin end market and strengthens customer stickiness through integrated manufacturing and innovation. This structural shift helps diversify revenue mix and capture secular healthcare demand across regulated products and services.
Raised FY2026 guidance and margin improvement trend
Management's upward guidance and material gross margin improvement indicate operational execution and better mix (notably medical). If sustained, higher operating margins expand cushion against cost swings and support reinvestment in capacity and R&D, improving long-term earnings durability.
Negative Factors
Thin margins and modest profitability
Margins remain thin in a contract-manufacturing model where pricing and component cost pressures are common. Low net margins leave limited room for error from input cost swings, program delays or competitive pricing, constraining durable free-cash flow expansion and ROI on new investments.
End-market concentration and Automotive weakness
Heavy reliance on automotive exposes the business to cyclicality, program transitions, tariffs and regional softness (China, North America). A single vertical near half of revenue raises the risk that prolonged auto weakness materially depresses revenue, utilization and margins over multiple quarters.
Near-term ramp costs and historical cash volatility
New facility ramps increase short-term overhead, working-capital needs and depreciation, pressuring margins until utilization improves. Combined with a history of volatile cash flow in down cycles, this raises execution risk: prolonged ramps or demand softness can depress returns and strain funding flexibility.

Kimball Electronics (KE) vs. SPDR S&P 500 ETF (SPY)

Kimball Electronics Business Overview & Revenue Model

Company DescriptionKimball Electronics, Inc. provides contract electronics manufacturing services and diversified manufacturing services to customers in the automotive, medical, industrial, and public safety end markets. The company's manufacturing services include design services and support, supply chain services and support, and rapid prototyping and product introduction support services, as well as product design, and process validation and qualification services. Its manufacturing services also comprise industrialization and automation of manufacturing processes; reliability testing, including testing of products under a series of environmental conditions; production and testing of printed circuit board assemblies; assembly, production, and packaging of medical devices and disposables, and other non-electronic products; drug delivery devices and solutions with and without electronics; design engineering and manufacturing of automation equipment, test and inspection equipment, and precision molded plastics; software design services; and product life cycle management services. The company operates in the United States, China, Mexico, Poland, Romania, Thailand, and Vietnam. Kimball Electronics, Inc. was founded in 1961 and is headquartered in Jasper, Indiana.
How the Company Makes MoneyKimball Electronics makes money primarily by selling manufacturing and related services to OEM customers under contract, recognizing revenue when it produces and delivers electronic assemblies and finished products that meet customer specifications. Key revenue streams typically include: (1) electronics manufacturing services—charging customers for the build of printed circuit board assemblies and higher-level assemblies (labor, overhead, manufacturing execution, and process engineering) and earning a margin on those services; (2) materials and component procurement—sourcing components on behalf of customers, incorporating those materials into finished goods, and generating revenue that includes reimbursement for materials plus a contracted margin/markup or embedded margin in the overall product price; (3) value-added services—engineering support, testing, quality/regulatory support (especially in medical and automotive), and new product introduction/industrialization services that help customers ramp production and sustain products over their life cycle. The company’s earnings are influenced by production volumes from existing programs, successful wins and ramps of new programs, the mix of higher-value assemblies vs. lower-complexity builds, operational efficiency/yield, and its ability to manage supply-chain availability and component cost volatility while meeting contractual pricing terms. Information on specific customer partnerships, named customers, or the exact contractual fee structures used (e.g., cost-plus vs. fixed-price by program) is null.

Kimball Electronics Earnings Call Summary

Earnings Call Date:Feb 04, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:May 12, 2026
Earnings Call Sentiment Positive
Balanced but cautiously optimistic. The company delivered clear progress on strategic initiatives — notably strong Medical growth (+15% YoY), improved gross and operating margins (+160 bps gross margin improvement; adjusted operating income up to 4.5% of sales), positive operating cash flow for eight consecutive quarters, reduced net debt versus prior year and raised FY26 revenue and margin guidance. Offsetting these positives are a 5% decline in consolidated sales, a material 13% decline in Automotive (48% of sales), near-term margin drag from the Indianapolis CMO ramp, and an unusually high Q2 tax rate. Given the combination of sustainable Medical momentum, raised guidance and improved margins and liquidity, tempered by near-term headwinds in Automotive/Industrial and facility ramp costs, the call skews positive overall.
Q2-2026 Updates
Positive Updates
Medical Vertical Strong Growth
Medical sales of $96.0M in Q2, up 15% year-over-year and representing 28% of company sales; fourth consecutive quarter of YoY revenue growth in Medical with growth driven by Poland and Thailand and balanced contributions across North America, Europe and Asia.
Raised Full-Year Guidance
Fiscal 2026 net sales guidance raised to $1.40B–$1.46B (prior: $1.35B–$1.45B) driven by Medical strength and Automotive program ramps in Europe; adjusted operating income guidance increased to 4.2%–4.5% of net sales (prior: 4.0%–4.25%).
Gross Margin and Operating Margin Improvement
Q2 gross margin rate improved to 8.2% from 6.6% in prior-year period, a +160 basis point improvement; adjusted operating income of $15.3M, or 4.5% of net sales, versus $13.3M or 3.7% last year.
Positive Operating Cash Flow and Strong Liquidity
Operating cash flow in Q2 was $6.9M — the eighth consecutive quarter of positive cash from operations. Cash and cash equivalents of $77.9M and combined short-term liquidity (cash + unused credit) of $363M at quarter end.
Lower Interest Expense and Reduced Debt
Other expense improved to $3.8M from $4.8M a year ago with interest expense down ~50% YoY. Total borrowings of $154M were down ~$51M (~25%) compared to a year ago.
Inventory and Working Capital Progress
Inventory decreased to $281.7M, down $24.5M (8%) year-over-year. Cash conversion days were 91 days, a 16-day improvement versus Q2 FY25 despite an 8-day increase from the prior quarter; management expects continuing focus and improvement.
Strategic Investments and New CMO Capacity
Grand opening of a 300,000 sq ft medical CMO facility in Indianapolis (adds U.S. capacity for single-use surgical instruments, drug delivery devices and plastic injection molding). Company is rebranding to "Kimball Solutions" to reflect expanded capabilities and pursuing disciplined M&A to expand customers and capabilities.
Shareholder Returns
Repurchased $4.3M of stock in Q2 (149,000 shares); since program inception $109.5M returned to shareholders (6.8M shares) with $10.5M remaining on the repurchase authorization.
Negative Updates
Overall Sales Decline
Consolidated net sales of $341.3M in Q2, down 5% year-over-year. Sequentially sales fell just over 6% versus Q1, driven primarily by weakness in the Industrial vertical.
Automotive Revenue Pressure
Automotive sales of $162M, down 13% year-over-year and representing 48% of company sales. Decline driven by lower North American sales due to an electronic braking program transferred out of Reynosa and tariff-related pressures; continued softness in China partially contributed.
Industrial End-Market Weakness
Industrial sales of $83M, down 5% year-over-year and 24% of company sales; decline concentrated in North America with lower demand for HVAC systems (partially offset by smart meter rebound in Europe).
Adjusted Net Income Slightly Lower
Adjusted net income of $6.9M ($0.28 diluted EPS) versus $7.4M ($0.29) in prior-year period — a modest decline in profitability on a reported adjusted net income basis.
Quarterly Tax Rate Spike
Effective tax rate unusually high at 47.9% in Q2 versus 1.2% last year due to a provision to tax return adjustment and valuation allowance adjustment related to expected sale of the Tampa facility; full-year tax rate still expected in the high 20s to low 30s.
Near-Term Margin Drag from New Facility
Management expects the Indianapolis CMO facility to be a near-term drag on margins for 2–3 quarters due to running both facilities, higher depreciation and ramp costs, despite longer-term margin upside potential in the CMO business.
Regional Softness and Operating Risks
Continued softness in China, sensitivity to tariffs and U.S. policy (tax subsidies) could pressure North American Automotive and Industrial demand; management is monitoring FY27 risks and tariff impacts.
Company Guidance
Management raised fiscal 2026 guidance to net sales of $1.40–$1.46 billion (up from $1.35–$1.45B previously) and now expects adjusted operating income of 4.2%–4.5% of sales (prior 4.0%–4.25%); capital expenditures remain guided at $50–$60 million and the full‑year effective tax rate is expected in the high‑20s to low‑30s. They cited Q2 results of $341.3 million in sales (Medical $96M, Automotive $162M, Industrial $83M), eight consecutive quarters of positive operating cash flow, cash and cash equivalents of $77.9M, borrowings of $154M, total near‑term liquidity of $363M, cash conversion days of 91 (16‑day improvement YoY), inventory of $281.7M (down 8% YoY), and $10.5M remaining on the share‑repurchase authorization, while noting the Indianapolis CMO grand opening and other strategic investments will add near‑term depreciation and expense that will partially offset the benefits of higher sales.

Kimball Electronics Financial Statement Overview

Summary
Overall fundamentals are mixed: revenue is slightly down in TTM and margins remain thin (gross ~7.4%, net ~1.6%), limiting return potential. Offsetting this, recent cash generation is solid (TTM FCF $110M) and leverage appears improved versus prior years (debt-to-equity ~0.24–0.26).
Income Statement
58
Neutral
TTM (Trailing-Twelve-Months) revenue is slightly down (-1.09%) versus the prior period, extending a softer top-line trend after prior declines, which weighs on the outlook. Profitability is positive but thin: TTM gross margin is ~7.4% and net margin is ~1.6%, indicating limited room for error in a cost-sensitive manufacturing model. Earnings improved from the weaker FY2025 level (annual net margin ~1.1%) but remain well below the stronger FY2023–FY2021 period when margins were materially higher.
Balance Sheet
62
Positive
Leverage appears moderate-to-improving versus the last few fiscal years, with the debt-to-equity ratio around 0.24–0.26 in the most recent periods (TTM and FY2025), down from ~0.54 in FY2024–FY2023. Returns on equity are positive but modest recently (TTM ~4.3% and FY2025 ~3.0%) versus stronger historical levels (e.g., FY2023 ~10.7% and FY2021 ~12.8%), suggesting profitability, rather than balance sheet structure, is the main limiter. Note: the TTM snapshot lists total debt and equity as 0, so the leverage assessment relies primarily on the provided debt-to-equity and ROE figures.
Cash Flow
67
Positive
Cash generation is a relative strength: TTM operating cash flow is $124M and free cash flow is $110M, following very strong FY2025 free cash flow of $150M. That said, free cash flow growth is slightly negative in TTM (-4.76%), and the company has shown meaningful volatility historically, including negative operating and free cash flow in FY2023 and FY2022. Overall, recent cash conversion is solid, but the track record suggests sensitivity to working-capital swings and/or cycle-driven demand shifts.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue1.46B1.49B1.71B1.82B1.35B1.29B
Gross Profit114.23M104.40M140.26M156.16M104.60M118.03M
EBITDA85.15M77.97M86.07M123.42M75.80M106.24M
Net Income24.12M16.98M20.51M55.83M31.25M56.79M
Balance Sheet
Total Assets1.08B1.08B1.21B1.26B1.04B814.06M
Cash, Cash Equivalents and Short-Term Investments77.85M88.78M77.97M42.95M49.85M106.44M
Total Debt153.81M147.05M294.84M281.45M180.58M66.21M
Total Liabilities504.31M507.43M667.46M735.73M581.80M372.09M
Stockholders Equity579.16M569.88M540.46M523.99M453.97M441.97M
Cash Flow
Free Cash Flow110.30M150.26M27.14M-104.49M-157.89M90.74M
Operating Cash Flow123.95M183.94M73.22M-13.80M-83.18M130.09M
Investing Cash Flow-37.85M-14.70M-46.52M-90.47M-74.80M-38.80M
Financing Cash Flow-65.76M-160.87M8.97M99.18M103.74M-53.08M

Kimball Electronics Technical Analysis

Technical Analysis Sentiment
Negative
Last Price23.27
Price Trends
50DMA
26.92
Negative
100DMA
27.90
Negative
200DMA
25.93
Negative
Market Momentum
MACD
-1.11
Negative
RSI
39.39
Neutral
STOCH
50.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KE, the sentiment is Negative. The current price of 23.27 is below the 20-day moving average (MA) of 24.25, below the 50-day MA of 26.92, and below the 200-day MA of 25.93, indicating a bearish trend. The MACD of -1.11 indicates Negative momentum. The RSI at 39.39 is Neutral, neither overbought nor oversold. The STOCH value of 50.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KE.

Kimball Electronics Risk Analysis

Kimball Electronics disclosed 27 risk factors in its most recent earnings report. Kimball Electronics reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Kimball Electronics Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
$165.04M11.5619.09%3.00%4.90%31.13%
71
Outperform
$1.24B28.817.68%0.35%15.93%12.72%
64
Neutral
$115.38M-16.14-4.35%12.94%-81.09%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
$565.64M47.054.24%-10.46%88.34%
54
Neutral
$231.47M-4.12-703.65%7.06%12.25%
47
Neutral
$224.56M-17.67-0.34%-100.27%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KE
Kimball Electronics
23.36
6.36
37.41%
ESP
Espey Mfg & Electronics
55.78
30.44
120.13%
PLPC
Preformed Line Products Company
253.55
103.06
68.48%
ULBI
Ultralife
6.93
1.35
24.19%
SKYX
SKYX Platforms
1.76
0.59
50.43%
AIRJ
Montana Technologies
3.36
-4.19
-55.50%

Kimball Electronics Corporate Events

Business Operations and Strategy
Kimball Electronics Unveils New Indianapolis Medical Manufacturing Facility
Positive
Jan 8, 2026

On January 8, 2026, Kimball Electronics announced it will hold a ribbon-cutting ceremony on February 6, 2026, to mark the opening of its new advanced medical manufacturing and innovation facility in Indianapolis, which will serve the medical and life sciences industries and is expected to expand the company’s manufacturing capacity and local community presence. The company also revealed plans to rebrand as Kimball Solutions, Inc., beginning with a phased global rollout in July 2026 subject to necessary approvals, a move that reflects its broadened capabilities and solutions-driven strategy and is intended to reinforce its long-term commitment to innovation, comprehensive customer solutions, and growth in the EMS and CMO markets.

The most recent analyst rating on (KE) stock is a Buy with a $32.00 price target. To see the full list of analyst forecasts on Kimball Electronics stock, see the KE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026